Case 17-2012: A 54-Year-Old Man with Visual-Field Loss and a Mass in the Brain

被引：1

作者：

Batchelor, Tracy T. ^{[1
,4
]}

Sorensen, A. Gregory ^{[2
,5
]}

Louis, David N. ^{[3
,6
]}

机构：

[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[4] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA

[5] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA

[6] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 22期

关键词：

NEWLY-DIAGNOSED GLIOBLASTOMA; PROMOTER METHYLATION STATUS; TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT; ADJUVANT; SURGERY; GLIOMAS; TRIAL;

D O I：

10.1056/NEJMcpc1111574

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2112 / 2120

页数：9

共 14 条

[1]

[Anonymous], 1990, N ENGL J MED, V322, P1866

[2]

BARNARD RO, 1987, CANCER-AM CANCER SOC, V60, P1519, DOI 10.1002/1097-0142(19871001)60:7<1519::AID-CNCR2820600719>3.0.CO

[3]

2-1

[4] PROBLEM OF MULTICENTRIC GLIOMAS [J].

BATZDORF, U ;

MALAMUD, N .

JOURNAL OF NEUROSURGERY, 1963, 20 (02) :122-+

[5] MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients [J].

Brandes, Alba A. ;

Franceschi, Enrico ;

Tosoni, Alicia ;

Blatt, Valeria ;

Pession, Annalisa ;

Tallini, Giovanni ;

Bertorelle, Roberta ;

Bartolini, Stefania ;

Calbucci, Fabio ;

Andreoli, Alvaro ;

Frezza, Giampiero ;

Leonardi, Marco ;

Spagnolli, Federica ;

Ermani, Mario .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2192-2197

[6] O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications [J].

Brandes, Alba A. ;

Franceschi, Enrico ;

Tosoni, Alicia ;

Bartolini, Stefania ;

Bacci, Antonella ;

Agati, Raffaele ;

Ghimenton, Claudio ;

Turazzi, Sergio ;

Talacchi, Andrea ;

Skrap, Miran ;

Marucci, Gianluca ;

Volpin, Lorenzo ;

Morandi, Luca ;

Pizzolitto, Stefano ;

Gardiman, Marina ;

Andreoli, Alvaro ;

Calbucci, Fabio ;

Ermani, Mario .

NEURO-ONCOLOGY, 2010, 12 (03) :283-288

[7] Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status [J].

Brandes, Alba A. ;

Tosoni, Alicia ;

Franceschi, Enrico ;

Sotti, Guido ;

Frezza, Giampiero ;

Amista, Pietro ;

Morandi, Luca ;

Spagnolli, Federica ;

Ermani, Mario .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1275-1279

[8] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma [J].

Friedman, Henry S. ;

Prados, Michael D. ;

Wen, Patrick Y. ;

Mikkelsen, Tom ;

Schiff, David ;

Abrey, Lauren E. ;

Yung, W. K. Alfred ;

Paleologos, Nina ;

Nicholas, Martin K. ;

Jensen, Randy ;

Vredenburgh, James ;

Huang, Jane ;

Zheng, Maoxia ;

Cloughesy, Timothy .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4733-4740

[9] Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide [J].

Gerstner, Elizabeth R. ;

Eichler, April F. ;

Plotkin, Scott R. ;

Drappatz, Jan ;

Doyle, Colin L. ;

Xu, Lei ;

Duda, Dan G. ;

Wen, Patrick Y. ;

Jain, Rakesh K. ;

Batchelor, Tracy T. .

JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (02) :325-332

[10] MGMT gene silencing and benefit from temozolomide in glioblastoma [J].

Hegi, ME ;

Diserens, A ;

Gorlia, T ;

Hamou, M ;

de Tribolet, N ;

Weller, M ;

Kros, JM ;

Hainfellner, JA ;

Mason, W ;

Mariani, L ;

Bromberg, JEC ;

Hau, P ;

Mirimanoff, RO ;

Cairncross, JG ;

Janzer, RC ;

Stupp, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003

← 1 2 →